SinoTau Pharmaceuticals' IPO

SinoTau Pharmaceuticals raised a round of funding on August 20, 2016. Investors include Public.

SinoTau Pharmaceuticals (先通医药) is a healthcare company engaged in the research, development, and manufacture of generics, novel antibodies, and nuclear medicine (radiopharmaceutical) products.…

Articles about SinoTau Pharmaceuticals' IPO: